Loading clinical trials...
Loading clinical trials...
Pilot Study for Therapy Optimising for Hodgkin's Lymphoma in Childhood and Adolescence; Optimising Therapy for Boys With Hodgkin's Lymphoma in Intermediate and Advanced Stages. Safety and Efficacy Study for Drug Combination VECOPA
Conditions
Interventions
cyclophosphamide
doxorubicin hydrochloride
+5 more
Locations
12
Germany
Klinikum Augsburg
Augsburg, Germany
Charite University Medical Center of Berlin
Berlin, Germany
Medizinische Universitaetsklinik I at the University of Cologne
Cologne, Germany
Universitaets - Kinderklinik
Erlangen, Germany
Universitaetsfrauenklinik Frankfurt
Frankfurt, Germany
Universitaetsklinikum Halle
Halle, Germany
Start Date
June 1, 2005
Primary Completion Date
October 1, 2012
Completion Date
March 1, 2013
Last Updated
March 26, 2020
NCT05139017
NCT07388563
NCT06263491
NCT06337318
NCT05529069
NCT07350863
Lead Sponsor
Christine Mauz-Körholz
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions